About this trial
The main objective is to evaluate the efficacy of a group-based mindfulness therapy programme in reducing distress associated with symptoms of UHR (Ultra High Risk) or FEP (first psychotic episode) compared with usual treatment. The secondary objectives were to study the efficacy of a group-based mindfulness intervention: on the reduction of psychotic symptoms; on the maintenance over time (6 months of follow-up) of the efficacy of the intervention on the distress associated with the symptoms of the UHR or PEP state; and on various dimensions associated with care: cognitive functions, anxiety, quality of life.
Eligibility criteria
Qualifiers
People aged between 18 and 30 validating the criteria for UHR or PEP status on the CAARMS scale and having a social functional impact (SOFAS score below 50 or a reduction of more than 30% in the score)
Disqualifiers
Previous episode of schizophrenic disorder, schizoaffective disorder or bipolar disorder
Previous antipsychotic treatment for more than 12 months
Organic mental disorder or intellectual disability
Serious suicidal/homicidal risk (but admissible if this risk has been resolved)
Trial design
Treatments tested in this trial
- MBTP : Mindflulness based training for psychosis